stockrow
Friday 6 November 2026
Export ACON’s income statement to Excel — free account
Aclarion, Inc.
ACON Healthcare Health Information Services
Aclarion, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75,700.00, up 65.6% from fiscal 2024.
- Revenue
- +78.5%
- EPS
- +67.9%
- Free cash flow
- −74.2%
Quarter to September 2026, against a year earlier
1.66
0.10
+6.41%
Follow ACON
Alert me
| Dec '17 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 7 | 5 | 5 | 3 | 5 |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | — | (21.69) | (32.30) | (41.92) | (4.92) |
P/S ratio |
— | 42.77 | 42.77 | 42.77 | 74.30 | 29.84 | 34.68 | 32.33 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | (98.24) | (131.66) | (90.21) | (51.19) | (77.31) | (96.28) | 4.23 |
Beneish M-Score |
— | — | — | — | — | — | — | (7.47) |
P/Operating CF |
— | (7.95) | (7.95) | (7.95) | (3.95) | (3.07) | (1.72) | (1.50) |
P/B ratio |
— | 0.00 | 0.00 | 0.00 | 2.02 | 0.00 | 1.63 | 0.19 |
Price to Tangible BV |
— | 0.00 | 0.00 | 0.00 | 4.42 | 0.00 | 0.00 | 0.21 |
EV/Sales |
— | 46.01 | 46.01 | 46.01 | 53.84 | 19.46 | 29.94 | (123.47) |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.37 |
EV/Operating CF |
— | (1.10) | (1.10) | (1.10) | (0.66) | (0.40) | (0.26) | 1.30 |
EV/FCF |
— | (1.03) | (1.03) | (1.03) | (0.63) | (0.39) | (0.24) | 1.27 |
Quick Ratio |
— | 0.05 | 0.00 | 0.06 | 2.18 | 0.33 | 0.42 | 14.42 |
Current Ratio |
— | 0.07 | 0.01 | 0.10 | 2.47 | 0.40 | 0.71 | 14.81 |
Net Debt/EBITDA |
— | (0.11) | (0.05) | 0.16 | 0.27 | 0.24 | 0.10 | 1.76 |
Debt/Assets |
0.00% | 37.61% | 19.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | (0.32) | (0.03) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.02 | 0.01 |
Operating CF/Net income |
— | 0.86 | 0.33 | 0.40 | 0.66 | 0.74 | 0.75 | 0.99 |
Capex/Depreciation |
— | 0.00 | (0.91) | (0.55) | (1.45) | (0.18) | (0.48) | (0.90) |
Interest Coverage |
— | (1,605.64) | (28.68) | (6.22) | (3.69) | (8.02) | (10.30) | — |
| — | 0.00% | 124.90% | 59.81% | 141.13% | (655.73%) | (5,826.19%) | (104.89%) | |
| — | (677.67%) | (403.12%) | (374.43%) | (311.57%) | (182.77%) | (307.75%) | (91.67%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | (467.71%) | 0.00% | (680.42%) | (554.92%) |
Return on Tangible Assets |
— | 169.15% | 66.49% | 86.64% | (736.84%) | 258.96% | 2,179.42% | (62.50%) |
Average Days of Receivables |
— | 199.46 | 168.63 | 38.13 | 112.40 | 64.38 | 146.16 | 143.20 |
Research and Development Expense of Revenue |
— | 6,234.94% | 2,160.37% | 1,306.63% | 1,768.21% | 1,158.22% | 1,944.86% | 1,365.65% |
Selling, General and Administrative Expense of Revenue |
— | 8,107.81% | 2,890.55% | 3,575.95% | 7,431.62% | 5,308.09% | 10,033.48% | 7,959.58% |
Intangible Assets out of Total Assets |
0.00 | 0.81 | 0.90 | 0.61 | 0.42 | 0.48 | 0.61 | 0.09 |
Share Based Compensation of Revenue |
— | 0.00% | 53.59% | 294.36% | 1,964.74% | 604.77% | 629.10% | 139.23% |
Graham Net Nets |
— | (3.32) | (3.32) | (3.32) | 0.23 | (0.84) | (0.21) | 4.72 |
Graham Number |
— | 0.00 | 0.00 | 6,626,120.88 | 0.00 | 133,081.06 | 0.00 | 0.00 |
Earnings Yield |
— | (262.22%) | (262.22%) | (262.22%) | (377.27%) | (271.36%) | (641.26%) | (381.30%) |
Free Cash Flow Yield |
— | (104.67%) | (104.67%) | (104.67%) | (114.91%) | (167.11%) | (352.84%) | (301.29%) |
Revenue per Share |
— | 8,674.06 | 7,781.79 | 9,635.36 | 1,431.66 | 1,216.13 | 50.78 | 0.14 |
Operating CF per Share |
— | (1,345,027.73) | (286,631.94) | (383,480.87) | (117,308.39) | (58,820.97) | (5,857.33) | (13.47) |
Capex per Share |
— | 0.00 | (28,602.47) | (16,298.62) | (4,927.85) | (1,927.42) | (357.67) | (0.38) |
Free Cash Flow per Share |
— | (1,345,027.73) | (315,234.41) | (399,779.49) | (122,236.23) | (60,748.39) | (6,215.00) | (13.85) |
Cash per Share |
— | 41,338.84 | 2,396.86 | 72,305.14 | 35,146.77 | 16,630.65 | 515.22 | 22.63 |
Shareholders Equity per Share |
— | (548,787.57) | (1,131,890.96) | (915,486.88) | 52,762.82 | (11,741.94) | 1,077.89 | 24.13 |
Interest Debt per Share |
— | 0.17 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | (548,787.57) | (1,131,890.96) | (915,486.88) | 52,762.82 | (11,741.94) | 1,077.89 | 24.13 |
Free Cash Flow |
— | (4.17) | (1.97) | (2.50) | (5.16) | (3.77) | (5.59) | (7.37) |
Working Capital |
— | (2.91) | (8.28) | (6.89) | 1.01 | (1.90) | (0.33) | 11.56 |
Capital Expenditures |
— | (0.27) | (0.18) | (0.10) | (0.21) | (0.12) | (0.32) | (0.20) |
Net Current Asset Value |
— | (2.91) | (8.28) | (6.89) | 1.01 | (1.90) | (0.33) | 11.56 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.33 |
Capex to Sales |
— | 0.00 | 3.68 | 1.69 | 3.44 | 1.58 | 7.04 | 2.69 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||
Depreciation/Fixed assets |
— | 3.67 | 7.67 | 14.79 | 43.52 | 366.83 | 120.82 | 9.40 |
Cash ROIC |
— | 402.74% | 28.92% | 47.41% | (139.05%) | (1,242.63%) | (390.12%) | (29.62%) |
Accounts Receivable Turnover |
— | 0.00 | 2.62 | 4.19 | 4.85 | 4.73 | 2.89 | 3.15 |
Accounts Payable Turnover |
— | 0.00 | 0.08 | 0.06 | 0.09 | 0.12 | 0.13 | 0.16 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 1,004.75 | 6,325.20 | 5,619.00 | 2,583.51 | 3,666.88 | 2,290.84 | 1,764.08 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
Average Payables |
— | — | 0.82 | 1.11 | 0.76 | 0.61 | 0.65 | 0.43 |
Average Assets |
— | 0.72 | 1.36 | 1.59 | 2.40 | 2.69 | 2.29 | 7.90 |
Average Common Equity |
— | — | (4.39) | (9.96) | (5.30) | 0.75 | 0.12 | 6.90 |
Columns are period end dates · fundamentals updated 5 Nov 2026